{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:35:45Z","timestamp":1794328545824,"version":"4.9.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8122801"],"award-info":[{"award-number":["8122801"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Osteoporosis is an osteolytic disease that features enhanced osteoclast formation and bone resorption. Identification of agents that can inhibit osteoclast formation and function is important for the treatment of osteoporosis. Dihydroartemisinin is a natural compound used to treat malaria but its role in osteoporosis is not known. Here, we found that dihydroartemisinin can suppress RANKL-induced osteoclastogenesis and bone resorption in a dose-dependent manner. Dihydroartemisinin inhibited the expression of osteoclast marker genes such as cathepsin K, calcitonin receptor, and tartrate-resistant acid phosphatase (TRAcP). Furthermore, dihydroartemisinin inhibited RANKL-induced NF-\u03baB and NFAT activity. In addition, using an in vivo ovariectomized mouse model, we show that dihydroartemisinin is able to reverse the bone loss caused by ovariectomy. Together, this study shows that dihydroartemisinin attenuates bone loss in ovariectomized mice through inhibiting RANKL-induced osteoclast formation and function. This indicates that dihydroartemisinin, the first physiology or medicine nobel prize discovery of China, is a potential treatment option against osteolytic bone disease. \u00a9 2015 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2771","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T02:45:17Z","timestamp":1450493117000},"page":"964-974","source":"Crossref","is-referenced-by-count":97,"title":["Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways"],"prefix":"10.1093","volume":"31","author":[{"given":"Lin","family":"Zhou","sequence":"first","affiliation":[{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"},{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"},{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Cheng","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"},{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Lin","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tickner","sequence":"additional","affiliation":[{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative MedicineGuangxi Medical UniversityGuangxiChina"},{"name":"School of Pathology and Laboratory MedicineThe University of Western AustraliaPerthWestern AustraliaAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"issue":"10","key":"2024021014181792700_jbmr2771-bib-0001","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI13073","article-title":"Osteolysis and cancer","volume":"107","author":"Goltzman","year":"2001","journal-title":"J Clin Invest"},{"issue":"3","key":"2024021014181792700_jbmr2771-bib-0002","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024021014181792700_jbmr2771-bib-0003","year":"2004"},{"issue":"2","key":"2024021014181792700_jbmr2771-bib-0004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","article-title":"Osteoporosis: impact on health and economics","volume":"6","author":"Harvey","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2024021014181792700_jbmr2771-bib-0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"6717","key":"2024021014181792700_jbmr2771-bib-0006","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"7","key":"2024021014181792700_jbmr2771-bib-0007","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0008","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2024021014181792700_jbmr2771-bib-0009","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2004.10.212","article-title":"RANK-L induces the expression of NFATc1, but not of NFkappaB subunits during osteoclast formation","volume":"326","author":"Zhu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2024021014181792700_jbmr2771-bib-0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.2009.05245.x","article-title":"Integrins, growth factors, and the osteoclast cytoskeleton","volume":"1192","author":"Zou","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"4703","key":"2024021014181792700_jbmr2771-bib-0011","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"issue":"11","key":"2024021014181792700_jbmr2771-bib-0012","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/jm00394a037","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives","volume":"30","author":"Lin","year":"1987","journal-title":"J Med Chem"},{"issue":"11","key":"2024021014181792700_jbmr2771-bib-0013","first-page":"976","article-title":"The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu","volume":"112","author":"Tu","year":"1999","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2024021014181792700_jbmr2771-bib-0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/432011","article-title":"A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria","volume":"41","author":"Ashley","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2024021014181792700_jbmr2771-bib-0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.toxlet.2003.12.009","article-title":"Artemisinin derivatives: toxic for laboratory animals, safe for humans","volume":"147","author":"Gordi","year":"2004","journal-title":"Toxicol Lett"},{"issue":"1\u20132","key":"2024021014181792700_jbmr2771-bib-0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0716-6","article-title":"Anti-tumor effects of dihydroartemisinin on human osteosarcoma","volume":"351","author":"Ji","year":"2011","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0017","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00432-012-1292-1","article-title":"Growth inhibitory effect of dihydroartemisinin on Bcr\/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-kappaB modulation","volume":"138","author":"Lee","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0018","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.bcp.2010.02.003","article-title":"Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha\/Raf\/MAPKs and NF-kappaB\/AP-1-dependent mechanisms","volume":"79","author":"Hwang","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2024021014181792700_jbmr2771-bib-0019","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00432-009-0731-0","article-title":"Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB","volume":"136","author":"Chen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"21","key":"2024021014181792700_jbmr2771-bib-0020","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.1074\/jbc.M901670200","article-title":"Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis","volume":"284","author":"Feng","year":"2009","journal-title":"J Biol Chem"},{"issue":"11","key":"2024021014181792700_jbmr2771-bib-0021","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1359\/jbmr.2000.15.11.2178","article-title":"Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand","volume":"15","author":"Xu","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0022","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bcp.2013.09.017","article-title":"SC-514, a selective inhibitor of IKKbeta attenuates RANKL-induced osteoclastogenesis and NF-kappaB activation","volume":"86","author":"Liu","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"2024021014181792700_jbmr2771-bib-0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-61779-415-5_2","article-title":"Osteoblast isolation from murine calvaria and long bones","volume":"816","author":"Bakker","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"25","key":"2024021014181792700_jbmr2771-bib-0024","doi-asserted-by":"crossref","first-page":"22035","DOI":"10.1074\/jbc.M110.187633","article-title":"EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase","volume":"286","author":"Chim","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"2024021014181792700_jbmr2771-bib-0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"2024021014181792700_jbmr2771-bib-0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0027","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer","volume":"70","author":"Ericsson","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2024021014181792700_jbmr2771-bib-0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","article-title":"Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells","volume":"70","author":"Singh","year":"2001","journal-title":"Life Sci"},{"issue":"6","key":"2024021014181792700_jbmr2771-bib-0029","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.7314\/APJCP.2014.15.6.2511","article-title":"Targeted efficacy of dihydroartemisinin for translationally controlled protein expression in a lung cancer model","volume":"15","author":"Liu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024021014181792700_jbmr2771-bib-0030","first-page":"1220","author":"Zuo","year":"2014"},{"issue":"5","key":"2024021014181792700_jbmr2771-bib-0031","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bmcl.2005.11.074","article-title":"Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane","volume":"16","author":"Jung","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"2024021014181792700_jbmr2771-bib-0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","article-title":"NF-kappaB modulators in osteolytic bone diseases","volume":"20","author":"Xu","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"2024021014181792700_jbmr2771-bib-0033","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2457","article-title":"The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis","volume":"10","author":"Brown","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2024021014181792700_jbmr2771-bib-0034","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0955-0674(99)80030-1","article-title":"Multiple signals converging on NF-kappaB","volume":"11","author":"Mercurio","year":"1999","journal-title":"Curr Opin Cell Biol"},{"issue":"45","key":"2024021014181792700_jbmr2771-bib-0035","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1203174","article-title":"NF-kappaB as a primary regulator of the stress response","volume":"18","author":"Mercurio","year":"1999","journal-title":"Oncogene"},{"issue":"5","key":"2024021014181792700_jbmr2771-bib-0036","first-page":"615","article-title":"NF-kappaB signaling","volume":"111","author":"Dixit","year":"2002","journal-title":"Many roads lead to Madrid. Cell"},{"issue":"11","key":"2024021014181792700_jbmr2771-bib-0037","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4161\/15384047.2014.955728","article-title":"Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis","volume":"15","author":"Dong","year":"2014","journal-title":"Cancer Biol Ther"},{"issue":"14","key":"2024021014181792700_jbmr2771-bib-0038","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1074\/jbc.M213067200","article-title":"The calcineurin\/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells","volume":"279","author":"Hirotani","year":"2004","journal-title":"J Biol Chem"},{"issue":"25","key":"2024021014181792700_jbmr2771-bib-0039","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin Biochem"},{"issue":"10","key":"2024021014181792700_jbmr2771-bib-0041","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"6951","key":"2024021014181792700_jbmr2771-bib-0042","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein-Ludwig","year":"2003","journal-title":"Nature"},{"issue":"8","key":"2024021014181792700_jbmr2771-bib-0043","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1359\/JBMR.050324","article-title":"Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production","volume":"20","author":"Yip","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024021014181792700_jbmr2771-bib-0044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1359\/JBMR.041213","article-title":"Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1","volume":"20","author":"Takatsuna","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014181792700_jbmr2771-bib-0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/me.2007-0237","article-title":"NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"22","author":"Kim","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"12","key":"2024021014181792700_jbmr2771-bib-0046","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/nm1514","article-title":"v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation","volume":"12","author":"Lee","year":"2006","journal-title":"Nat Med"},{"issue":"7","key":"2024021014181792700_jbmr2771-bib-0047","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1359\/jbmr.2003.18.7.1198","article-title":"Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity","volume":"18","author":"Nakamura","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024021014181792700_jbmr2771-bib-0048","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/emboj\/20.6.1271","article-title":"Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis","volume":"20","author":"Kobayashi","year":"2001","journal-title":"EMBO J"},{"issue":"5","key":"2024021014181792700_jbmr2771-bib-0049","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/ijmm.2015","article-title":"Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway","volume":"35","author":"Dong","year":"2015","journal-title":"Int J Mol Med"},{"issue":"2","key":"2024021014181792700_jbmr2771-bib-0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","article-title":"Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts","volume":"148","author":"Miyazaki","year":"2000","journal-title":"J Cell Biol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2771","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/5\/964\/56649326\/jbmr2771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/5\/964\/56649326\/jbmr2771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:55:40Z","timestamp":1710341740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/31\/5\/964-974\/7605174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,12,18]]},"published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2771","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,5,1]]},"published":{"date-parts":[[2015,12,18]]}}}